Graded A+
1. Discuss why long-term menopausal hormone therapy (MHT) is not routinely
prescribed for conditions like dementia or coronary heart disease.
Long-term MHT is not routinely prescribed for these conditions due
to potential risks and lack of evidence supporting its efficacy.
Long-term MHT is a first-line treatment for coronary heart disease.
Long-term MHT is beneficial for all conditions related to menopause.
Long-term MHT is only prescribed for osteoporosis.
2. Which estradiol vaginal ring is specifically indicated for treating both
vasomotor symptoms and vaginal dryness in post-menopausal women?
Vagifem (estradiol vaginal tablet)
Femring (estradiol vaginal ring)
Estring (estradiol vaginal ring)
Imvexxy (estradiol vaginal insert)
3. A post-menopausal woman using estradiol hemihydrate vaginal tablets is
concerned about her contraceptive options. What advice should you provide
regarding the use of latex condoms?
Use two latex condoms for added protection.
Continue using latex condoms as they are unaffected by estradiol
hemihydrate.
Consider using non-latex contraceptive methods to avoid potential
weakening of the condom.
Switch to oral contraceptives instead of using condoms.
,4. A 50-year-old woman reports persistent vaginal dryness and discomfort
despite using a topical moisturizer. Considering her age and symptoms, what
would be the most effective treatment option?
Combination oral estrogen and progestogen
Oral estrogen only
Intravaginal estrogen and oral progestogen
Intravaginal estrogen only
5. A 55 y.o. postmenopausal women presents to the office with moderate to
severe hot flashes. She has no history of breast cancer or cardiovascular
disease nor moderate to high risk of these diseases. Patient has a history of a
hysterectomy. What is the best treatment option?
Lifestyle changes only
Low-dose estrogen therapy
Low-dose, estrogen and progestin therapy
Paroxetine, citalopram, or escitalopram
6. Describe why increasing the daily dose of estrogen may be beneficial for a
postmenopausal woman experiencing vasomotor symptoms.
Increasing the dose of estrogen is unnecessary if the patient is already
on hormone therapy.
Increasing the dose of estrogen will not affect vasomotor symptoms.
Increasing the dose of estrogen may lead to more side effects without
addressing the symptoms.
Increasing the daily dose of estrogen can help alleviate vasomotor
symptoms by providing more hormonal support to balance the
effects of menopause.
, 7. A postmenopausal patient has an order to begin conjugated estrogen, a
hormone replacement. The nurse identifies which of the following conditions
in her health history that contradict the therapy?
Depression
Diabetes mellitus
History of breast cancer
Renal failure
8. Why is it important to allow 17β-estradiol topical gel to dry before dressing?
It prevents skin irritation from the gel.
It enhances the effectiveness of the gel immediately after application.
Allowing the gel to dry ensures proper absorption and minimizes
transfer to clothing.
It allows for better mixing with other topical products.
9. Continued vasomotor symptoms in a 52-year-old postmenopausal woman
with a history of hysterectomy receiving 0.3 mg of oral conjugated equine
estrogens can best be managed by:
Changing to gabapentin
Changing to a SERM
Decreasing the daily estrogen dose
Increasing the daily estrogen dose
10. A post-menopausal woman presents with significant vaginal dryness and
discomfort. If she is advised to use a vaginal tablet, which of the following
would be the most appropriate choice?